Dramatically elevated circulating tumor cell numbers in a patient with small cell neuroendocrine carcinoma of the prostate

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 1, 2010, Pages 120-123

  Chan, Fanny ^a   Goodman, Oscar ^a   Fink, Louis ^a   Vogelzang, Nicholas J ^a   Pomerantz, David ^a   Khoury, Joseph D ^a  

^a NEVADA CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD; CARCINOMA; CASE REPORT; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SMALL CELL CARCINOMA; TUMOR EMBOLISM;

CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 75149130102     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Nadig SN, Deibler AR, El Salamony TM, Hull GW, Bissada NK. Small cell carcinoma of the prostate: an underrecognized entity. Can J Urol. 2001;8(1): 1207-1210.
2. Ro JY, Tetu B, Ayala AG, Ordonez NG. Small cell carcinoma of the prostate, II: immunohistochemical and electron microscopic studies of 18 cases. Cancer. 1987;59(5):977-982. (Pubitemid 17024655)
3. Sarma DP, Weilbaecher TG. Small-cell carcinoma of prostate. Urology. 1989;33(4):332-335.
4. Slovin SF. Does small-cell phenotype predict the natural history of prostate cancer: a case study in disease behavior. Nat Clin Pract Oncol. 2007;4(9):551-554.
5. Wang W, Epstein JI. Small cell carcinoma of the prostate: a morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008;32(1):65-71.
6. Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res. 2007;13(23):7053-7058. (Pubitemid 350276887)
7. de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302-6309.
8. Moreno JG, Miller MC, Gross S, et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. 2005;65(4):713-718.
9. Moreno JG, O'Hara SM, Gross S, et al. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology. 2001;58(3):386-392.
10. Shaffer DR, Leversha MA, Danila DC, et al. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res. 2007;13(7):2023-2029.
11. Aygun C. Small cell carcinoma of the prostate: a case report and review of the literature. Md Med J. 1997;46(7):353-356.
12. Rubenstein JH, Katin MJ, Mangano MM, et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol. 1997;20(4):376-380.
13. Trotz C. Prostate cancer with a normal PSA: small cell carcinoma of the prostate-a rare entity. J Am Board Fam Pract. 2003;16(4):343-344.